15-12B - Pandion Therapeutics, Inc. (0001807901) (Filer)
EFFECT - Pandion Therapeutics, Inc. (0001807901) (Filer)
EFFECT - Pandion Therapeutics, Inc. (0001807901) (Filer)
S-8 POS - Pandion Therapeutics, Inc. (0001807901) (Filer)
S-8 POS - Pandion Therapeutics, Inc. (0001807901) (Filer)
POS AM - Pandion Therapeutics, Inc. (0001807901) (Filer)
POS AM - Pandion Therapeutics, Inc. (0001807901) (Filer)
8-K - Pandion Therapeutics, Inc. (0001807901) (Filer)
SC 14D9/A - Pandion Therapeutics, Inc. (0001807901) (Subject)
SC TO-T/A - Pandion Therapeutics, Inc. (0001807901) (Subject)
SVB Leerink resumed coverage of Pandion Therapeutics with a rating of Market Perform and set a new price target of $60.00
Morgan Stanley resumed coverage of Pandion Therapeutics with a rating of Equal Weight and set a new price target of $60.00 from $25.00 previously
Morgan Stanley downgraded Pandion Therapeutics from Overweight to Equal-Weight and set a new price target of $60.00 from $25.00 previously
SVB Leerink downgraded Pandion Therapeutics from Outperform to Market Perform and set a new price target of $60.00
Morgan Stanley downgraded Pandion Therapeutics from Overweight to Equal Weight
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)
4 - Pandion Therapeutics, Inc. (0001807901) (Issuer)